A practical method for quantifying dose in bone and lung using TLDs when using 6 and 15 MV photon beams.
Sarigul N, Surucu M, Reft C, Malin M, Yegingil Z, Aydogan B. A practical method for quantifying dose in bone and lung using TLDs when using 6 and 15 MV photon beams. Phys Med Biol. 2020 03 06; 65(5):05NT01.
PMID: 32028274
ENERGY RESPONSE FACTOR of BeO DOSEMETER CHIPS: A MONTE CARLO SIMULATION AND GENERAL CAVITY THEORY STUDY.
Sarigul N, Surucu M, Aydogan B. ENERGY RESPONSE FACTOR of BeO DOSEMETER CHIPS: A MONTE CARLO SIMULATION AND GENERAL CAVITY THEORY STUDY. Radiat Prot Dosimetry. 2019 Dec 31; 185(3):303-309.
PMID: 30806472
Technical Note: High temporal resolution characterization of gating response time.
Wiersma RD, McCabe BP, Belcher AH, Jensen PJ, Smith B, Aydogan B. Technical Note: High temporal resolution characterization of gating response time. Med Phys. 2016 Jun; 43(6):2802-2806.
PMID: 27277028
Part I-mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways.
Aqil M, Elseth KM, Vesper BJ, Deliu Z, Aydogan B, Xue J, Radosevich JA. Part I-mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways. Tumour Biol. 2014 Mar; 35(3):2403-15.
PMID: 24241898
Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines.
Vesper BJ, Onul A, Haines GK, Tarjan G, Xue J, Elseth KM, Aydogan B, Altman MB, Roeske JC, Paradise WA, De Vitto H, Radosevich JA. Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines. Tumour Biol. 2013 Feb; 34(1):203-14.
PMID: 23238815
Verification of dose distribution for volumetric modulated arc therapy total marrow irradiation in a humanlike phantom.
Surucu M, Yeginer M, Kavak GO, Fan J, Radosevich JA, Aydogan B. Verification of dose distribution for volumetric modulated arc therapy total marrow irradiation in a humanlike phantom. Med Phys. 2012 Jan; 39(1):281-8.
PMID: 22225298
Total marrow irradiation with RapidArc volumetric arc therapy.
Aydogan B, Yeginer M, Kavak GO, Fan J, Radosevich JA, Gwe-Ya K. Total marrow irradiation with RapidArc volumetric arc therapy. Int J Radiat Oncol Biol Phys. 2011 Oct 01; 81(2):592-9.
PMID: 21345619
Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study.
Yeginer M, Roeske JC, Radosevich JA, Aydogan B. Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study. Int J Radiat Oncol Biol Phys. 2011 Mar 15; 79(4):1256-65.
PMID: 21035960
Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines.
Tarjan G, Haines GK, Vesper BJ, Xue J, Altman MB, Yarmolyuk YR, Khurram H, Elseth KM, Roeske JC, Aydogan B, Radosevich JA. Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines. Tumour Biol. 2011 Feb; 32(1):87-98.
PMID: 20963646
Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):800-7.
PMID: 20400238